Axon Therapies Inc. — Form D
Axon Therapies Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2019-02-07. The offering totals $150.0M, of which $75.0M was reported sold. Industry: Other Technology.
Offering
- Filed: 2019-02-07
- Form: D
- Accession: 0001671158-19-000001
- Industry: Other Technology
- Exemptions: 06b
- Total offering: $150.0M
- Amount sold: $75.0M
- Remaining: $75.0M
- Investors: 10
- Date of first sale: 2019-01-23
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-332379
Issuer
- Name: Axon Therapies Inc.
- CIK: 0001671158
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2014
- Address: C/O CORIDEA, LLC, NEW YORK, NY, 10018
- Phone: 212-929-6600
Officers, directors & promoters (9)
| Name | Role | Location |
|---|
| Steven S Hochberg | Director | New York, NY |
| Paul S LaViolette | Director | Tewksbury, MA |
| Andrew S ElBardissi | Director | Milford, MA |
| Mitchell S Bloom | Executive Officer | New York, NY |
| Mark R Gelfand | Director | New York, NY |
| Mark R Gelfand | Executive Officer | New York, NY |
| Howard R Levin | Director | New York, NY |
| Howard R Levin | Executive Officer | New York, NY |
| Imran S Eba | Director | New York, NY |
Other filings by this issuer (3)
More